肢端肥大症与椎体和髋部长期骨折风险:一项全国性队列研究
这项全国性队列研究纳入1777例40岁及以上肢端肥大症患者和8885例年龄性别匹配对照,随访约8.5年。肢端肥大症患者的临床椎体骨折(HR 2.09 [1.58-2.78])和髋部骨折(HR 2.52 [1.61-3.95])风险均显著高于对照,且骨折风险升高呈时间依赖性,在随访早期即可观察到。
要点
- 肢端肥大症患者临床椎体骨折风险显著高于对照(HR 2.09 [1.58-2.78])。
- 肢端肥大症患者髋部骨折风险显著高于对照(HR 2.52 [1.61-3.95])。
- 骨折风险升高呈时间依赖性,随访早期即可观察到。
核心结论
- 肢端肥大症患者的髋部骨折风险以及临床椎体骨折风险均高于对照。
- 肢端肥大症患者骨折风险升高呈时间依赖性,且在随访早期即可观察到。
研究设计与样本
- 全国性人群队列研究,纳入2006-2016年1777例40岁及以上肢端肥大症患者和8885例年龄性别匹配对照。
- 采用Cox比例风险模型估算校正风险比(HR)[95%置信区间]。
主要发现
- 平均年龄54.3岁,女性占58.9%。
- 随访约8.5年,多变量分析显示肢端肥大症患者临床椎体骨折风险显著高于对照(HR 2.09 [1.58-2.78])。
- 多变量分析显示肢端肥大症患者髋部骨折风险显著高于对照(HR 2.52 [1.61-3.95])。
- Kaplan-Meier生存分析显示肢端肥大症患者与对照的临床椎体骨折(P < 0.0001)和髋部骨折(P < 0.0001)风险差异显著。
- 比较肢端肥大症患者与对照,观察期内及排除前7年观察期的临床椎体骨折多变量校正HR分别为1.69 [1.15-2.49]和2.70 [1.75-4.17]。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: In this national cohort study, the patients with acromegaly had significantly higher risks of clinical vertebral (HR 2.09 [1.58-2.78]) and hip (HR 2.52 [1.61-3.95]) fractures than the controls. The increased fracture risk in patients with acromegaly was time-dependent and was observed even during the early period of follow-up. PURPOSE: Acromegaly is characterized by the overproduction of growth hormone (GH) and insulin-like growth factor-1 (IGF-1), both play important roles in regulating bone metabolism. We investigated the risk of vertebral and hip fractures in patients with acromegaly compared to age- and sex-matched controls. METHODS: This nationwide population-based cohort study included 1,777 patients with acromegaly aged 40 years or older in 2006-2016 and 8,885 age- and sex-matched controls. A Cox proportional hazards model was used to estimate the adjusted hazard ratio (HR) [95% confidence interval]. RESULTS: The mean age was 54.3 years and 58.9% were female. For approximately 8.5 years of follow-up, the patients with acromegaly had significantly higher risks of clinical vertebral (HR 2.09 [1.58-2.78]) and hip (HR 2.52 [1.61-3.95]) fractures than the controls in the multivariate analyses. There were significant differences in the risks of clinical vertebral (P < 0.0001) and hip (P < 0.0001) fractures between the patients with acromegaly and the controls in the Kaplan-Meier survival analysis. The multivariable-adjusted HRs for clinical vertebral fractures comparing the patients with acromegaly with controls during and excluding the first 7 years of observation were 1.69 [1.15-2.49] and 2.70 [1.75-4.17], respectively. The HRs for hip fractures during and excluding the first 7 years of observation were 2.29 [1.25-4.18] and 3.36 [1.63-6.92], respectively. CONCLUSIONS: The patients with acromegaly had a higher risk of hip fractures as well as clinical vertebral fractures than the controls. The increased fracture risk in patients with acromegaly was time-dependent and was observed even during the early period of follow-up.
引用
- Kwon H, Han KD, Kim BS, et al. Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study. Osteoporos Int. 2023. PMID: 37222744. doi:10.1007/s00198-023-06800-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。